2017
DOI: 10.1096/fj.201600857rrr
|View full text |Cite|
|
Sign up to set email alerts
|

Serum amyloid A: an ozone‐induced circulating factor with potentially important functions in the lung‐brain axis

Abstract: Accumulating evidence suggests that O 3 exposure may contribute to CNS dysfunction. Here, we posit that inflammatory and acute-phase proteins in the circulation increase after O 3 exposure and systemically convey signals of O 3 exposure to the CNS. To model acute O 3 exposure, female Balb/c mice were exposed to 3 ppm O 3 or forced air for 2 h and were studied after 6 or 24 h. Of 23 cytokines and chemokines, only KC/CXCL1 was increased in blood 6 h after O 3 exposure. The acute-phase protein serum amyloid A (A-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
52
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 40 publications
(59 citation statements)
references
References 89 publications
3
52
0
Order By: Relevance
“…In the chronic setting, excessive SAA production is a precursor to secondary amyloidosis that can cause serious complications [ 24 ], and amyloid deposits can also accumulate within the brains of patients with systemic amyloidosis, particularly around circumventricular organs that lack a contiguous BBB [ 25 ]. The acute SAA isoforms have been shown to readily cross the intact BBB, where radiolabelled SAA traversed the endothelial barrier to enter the brain parenchyma [ 15 ]. In a recent study, a liver-specific SAA over-expressing transgenic mouse model was used to evaluate whether acute circulating SAA can contribute to neurodegenerative disorders [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the chronic setting, excessive SAA production is a precursor to secondary amyloidosis that can cause serious complications [ 24 ], and amyloid deposits can also accumulate within the brains of patients with systemic amyloidosis, particularly around circumventricular organs that lack a contiguous BBB [ 25 ]. The acute SAA isoforms have been shown to readily cross the intact BBB, where radiolabelled SAA traversed the endothelial barrier to enter the brain parenchyma [ 15 ]. In a recent study, a liver-specific SAA over-expressing transgenic mouse model was used to evaluate whether acute circulating SAA can contribute to neurodegenerative disorders [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…AT-RvD1 allosterically modulates Fpr2 by actively opposing the actions of SAA to resolve lung inflammation and immunopathology [ 12 , 13 ]. Whilst SAA is known to efficiently enter the brain from the circulation [ 15 ], its role in neuroinflammation in the context of respiratory co-infection is unexplored. In addition, as acute inflammation increases Fpr2 expression in primary microglia [ 16 ], pro-resolving mediators that target this receptor may represent an important target for modulating the function of microglia.…”
Section: Introductionmentioning
confidence: 99%
“…The circulating inflammatory mediators that impair cognitive function during AECOPD are not well-characterized. However, circulating SAA can readily cross the intact blood-brain barrier ( 70 ) and excessive production of SAA in a transgenic model resulted in greater deposition in the brain and an increase in brain inflammation ( 71 ). Consistent with this study, we found that in our co-infection model associated with a marked increase in circulating SAA, there was an increase in SAA immuno-reactivity, increased numbers of “activated” amoeboid-shaped microglia and inflammatory cytokine expression in the brain ( 72 ).…”
Section: Targeting Bacterial Super-infections With Specialized Pro-rementioning
confidence: 99%
“…However, Baranova et al additionally report that (in cell culture) CLA-1/SR-BI ligands "efficiently compete" with SAA for CLA-1/SR-BI binding [63]. (For example, it has already been documented in the literature that both apoA-I and SAA are substrates for SR-BI, which indicates that SR-BI could mediate the transport of both proteins across the BBB (e.g., [65])). Not surprisingly, therefore, Robert et al have recently asserted that many lines of evidence suggest a protective role for HDL and its major apolipoprotein (apo)A-I in Alzheimer's disease [14].…”
Section: Gut-brain Axis Serum Amyloid a (Saa) Versus Sr-bi Targetingmentioning
confidence: 99%